| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 57.590 | 114.881 | 124.355 | 134.498 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 57.590 | 114.881 | 124.360 | 134.498 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 3.627 | 16.000 | 15.082 | 18.171 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 53.963 | 98.881 | 109.279 | 116.327 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 53.443 | 97.733 | 108.035 | 112.292 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anestezia Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 89 | 88 | 86 | 85 | 83 | 81 | 0 | 0 | 0 | 1.708 |
| Current Assets | 178 | 176 | 173 | 170 | 167 | 164 | 47.220 | 133.339 | 109.939 | 135.007 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 20.215 | 71.479 | 0 | 82.424 |
| Cash | 178 | 176 | 173 | 170 | 167 | 164 | 27.005 | 61.860 | 109.939 | 52.583 |
| Shareholders Funds | -8.510 | -8.423 | -8.280 | -8.128 | -7.971 | -7.820 | 45.797 | 97.784 | 108.086 | 112.343 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 8.776 | 8.687 | 8.540 | 8.383 | 8.221 | 8.065 | 1.423 | 35.555 | 1.853 | 24.372 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Anestezia Grup Srl